Xylem's decision to raise $1 billion through senior and blue notes is a double-edged sword of financial engineering. On one hand, the company successfully pushes out its maturity wall and secures funding for its core ESG-driven verticals. On the other, it accepts a higher cost of capital and a larger debt footprint. The ultimate impact on shareholder value will depend on whether the returns from the earmarked 'blue projects' can outpace the increased interest expense and whether the company can maintain its credit rating to avoid punitive repurchase triggers.